图共 6个 表共 0
    • 图  FIG. 529.  FIG. 529.

      Figure FIG. 529..  FIG. 529.

    • 图  1  Dox-HSA-FA的制备路线

      Figure 1.  Preparation route of Dox-HSA-FA

    • 图  2  Dox、HSA、FA、Dox-HSA-FA的(a)UV-Vis-Nir光谱图和(b)FT-IR光谱图

      Figure 2.  (a)UV-Vis-Nir spectra and (b)FT-IR spectra of Dox, HSA, FA and Dox-HSA-FA

    • 图  3  (a) SWCNTs分散液、(6,5)SWCNT的实物图和UV-Vis-Nir光谱图;(b) Dox-HSA-FA、(6,5)SWCNT、(6,5)SWCNT-Dox-HSA-FA的UV-Vis-Nir光谱图

      Figure 3.  (a) Photo of SWCNTs dispersion and (6,5) SWCNT, and UV-Vis-Nir spectra of SWCNTs dispersion and(6,5)SWCNT; (b) UV-Vis-Nir spectra of Dox-HSA-FA,(6,5)SWCNT, and (6,5)SWCNT-Dox-HSA-FA

    • 图  4  经Dox-HSA、Dox-HSA-FA、(6,5)SWCNT-Dox-HSA-FA作用24 h后Hep G2细胞的存活率

      Figure 4.  Cell viability of Hep G2 cells treated with Dox-HSA, Dox-HSA-FA,(6,5)SWCNT-Dox-HSA-FA for 24 h

    • 图  5  经SWCNTs-Dox-HSA-FA、(6,5)SWCNT-Dox-HSA-FA作用24、48、72 h后Hep G2细胞的存活率

      Figure 5.  Cell viability of Hep G2 cells treated with SWCNTs-Dox-HSA-FA and(6,5)SWCNT-Dox-HSA-FA for 24, 48, 72 h